相关实验视频

Updated: Jul 5, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

2015年至2022年期间,塞浦路斯的社区抗生素消费量

Eirini Mitsoura^1,2, Ioannis Kopsidas^1,3, Pambos Charalambous⁴

¹Medical School, European University of Cyprus, 2404 Nicosia, Cyprus.

Antibiotics (Basel, Switzerland)

|January 22, 2024

概括

塞浦路斯的社区抗生素消费从2015年到2022年增加了38%,使用率较低.

科学领域:

抗微生物药物管理管理
公共卫生公共卫生
药物监督药物监督药物监督

背景情况:

塞浦路斯向ESAC-Net报告了总计抗菌素消费数据,缺乏社区与医院使用的具体细节.
目前数据的局限性阻碍了对国家抗微生物药物趋势的细分洞察力.

研究的目的:

进行塞浦路斯社区抗生素消费的首次回顾性分析.
检查2015年至2022年的趋势.

主要方法:

利用Pharmatrack数据库用于社区抗菌药物发行数据 (2015-2022年).
使用世卫组织解剖治疗化学 (ATC) J01组和AWaRe分类进行分类的抗生素.
每1000名居民的计算消费,总体,按年,按地区.

主要成果:

在2015年至2022年期间,社区抗生素消费量增加了38%.
观察到世卫组织"准入"抗生素使用量下降了3%,同时"观察"组增加了3%.
在2022年",获取"抗生素消费量为48%,低于世卫组织 (60%) 和欧盟 (70%) 的目标.

结论:

社区抗生素消费的区级显著变化,人口较少的地区的比率更高.
观察到社区抗生素消费总体上升的趋势.
发现"准入"抗生素处方比例的下降趋势.

关键词:

现在还在等待消费抗生素消费抗生素消费抗微生物药物管理管理主要护理是一级医疗保健.

更多相关视频

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

相关概念视频

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Antibiotic Selection

Antibiotic Selection